arrow_back Back Filing freshness 10-Q Q4 FY2028 SEC EDGAR

download Export Data

TuHURA Biosciences, Inc./NV

HURA

$1.61 ▼ -0.11 (-6.40%) at close

53 Visible periods

21 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, TuHURA Biosciences, Inc./NV shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC —

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

53-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-7.54M

↓ -13.1% —

FCF / Share Free cash flow per share

$-0.14

↓ -84.4% —

Long-Term Debt Long-term obligations

$1.12K

↓ -96.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of -0.79x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q4 FY2028 Jun 30, 2019 10-K ↗	Q4 FY2027 Jun 30, 2018 10-K ↗	Q4 FY2026 Jun 30, 2017 10-K ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2013 10-Q ↗	Q4 FY2022 Jun 30, 2023 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2022 10-Q ↗	Q4 FY2021 Jun 30, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Sep 30, 2021 10-Q ↗	Q4 FY2020 Jun 30, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Sep 30, 2020 10-Q ↗	Q4 FY2019 Jun 30, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Dec 31, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Dec 31, 2018 10-Q ↗	Q1 FY2018 Sep 30, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-Q ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Dec 31, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-Q ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q1 FY2016 Sep 30, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-Q ↗	Q3 FY2015 Mar 31, 2015 10-Q ↗	Q2 FY2015 Dec 31, 2015 10-Q ↗	Q1 FY2015 Sep 30, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-Q ↗	Q3 FY2014 Mar 31, 2014 10-Q ↗	Q2 FY2014 Dec 31, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗
EPS Growth YoY (%)	—	—	—	33.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	13.3% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	74.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	51.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-96.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	72.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-79.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	-63.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	64.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	88.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	-118378.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	72.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-57282.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-45.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	81.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-74.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	46.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	-81.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	-42.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	53.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	—	—	—	-13.1% Weak ↑ Weak Improving Year-over-year change in net income	-13.1% Weak ↑ Weak Improving Year-over-year change in net income	-12.8% Weak ↑ Weak Improving Year-over-year change in net income	-37.6% Weak ↓ Weak Declining Year-over-year change in net income	-37.6% Weak ↓ Weak Declining Year-over-year change in net income	-37.6% Weak ↑ Weak Improving Year-over-year change in net income	66.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-48.3% Weak ↑ Weak Improving Year-over-year change in net income	-373.3% Weak ↓ Weak Declining Year-over-year change in net income	34.6% Excellent ↓ Excellent Declining Year-over-year change in net income	N/M	39.1% Excellent ↑ Excellent Improving Year-over-year change in net income	70.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-61.1% Weak ↓ Weak Declining Year-over-year change in net income	-71.2% Weak ↓ Weak Declining Year-over-year change in net income	19.3% Good ↓ Good Declining Year-over-year change in net income	41.4% Excellent ↑ Excellent Improving Year-over-year change in net income	23.0% Good ↑ Good Improving Year-over-year change in net income	N/M	-239.0% Weak → Weak Stable Year-over-year change in net income	-8.9% Weak ↑ Weak Improving Year-over-year change in net income	69.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-801.4% Weak ↓ Weak Declining Year-over-year change in net income	-17.6% Weak Weak Year-over-year change in net income	-211.1% Weak Weak Year-over-year change in net income	—	—	—	3.8% Caution Caution Year-over-year change in net income	—	—	—	42.8% Excellent Excellent Year-over-year change in net income	—	—	—	N/M	—	—	—	—	-41.3% Weak Weak Year-over-year change in net income	—	-57.1% Weak Weak Year-over-year change in net income	—	89.4% Excellent Excellent Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	—	—	—	—	32.5% Excellent Excellent Year-over-year change in free cash flow	—	17.5% Good Good Year-over-year change in free cash flow	—	65.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	93.6% Excellent Excellent Year-over-year change in free cash flow	14.8% Fair Fair Year-over-year change in free cash flow	—	—	41.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-256013.5% Weak Weak Year-over-year change in free cash flow	—	39.5% Excellent Excellent Year-over-year change in free cash flow	—	N/M	—	38.4% Excellent Excellent Year-over-year change in free cash flow	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-8.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-46.9% Weak Weak Compound annual EPS growth over 3 years	—	—	—	-46.0% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	10.1% Good Good Compound annual EPS growth over 3 years	-16.3% Weak Weak Compound annual EPS growth over 3 years	—	—	67.1% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q4 FY2028 Jun 30, 2019 10-K ↗	Q4 FY2027 Jun 30, 2018 10-K ↗	Q4 FY2026 Jun 30, 2017 10-K ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2013 10-Q ↗	Q4 FY2022 Jun 30, 2023 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2022 10-Q ↗	Q4 FY2021 Jun 30, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Sep 30, 2021 10-Q ↗	Q4 FY2020 Jun 30, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Sep 30, 2020 10-Q ↗	Q4 FY2019 Jun 30, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Dec 31, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Dec 31, 2018 10-Q ↗	Q1 FY2018 Sep 30, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-Q ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Dec 31, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-Q ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q1 FY2016 Sep 30, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-Q ↗	Q3 FY2015 Mar 31, 2015 10-Q ↗	Q2 FY2015 Dec 31, 2015 10-Q ↗	Q1 FY2015 Sep 30, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-Q ↗	Q3 FY2014 Mar 31, 2014 10-Q ↗	Q2 FY2014 Dec 31, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗
FCF / Net Income (x)	—	—	—	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.66x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.72x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.12x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.07x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.38x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	1.28x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.42x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-2.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	-0.98x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	-0.20x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 1 metrics

Metric	Q4 FY2028 Jun 30, 2019 10-K ↗	Q4 FY2027 Jun 30, 2018 10-K ↗	Q4 FY2026 Jun 30, 2017 10-K ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2013 10-Q ↗	Q4 FY2022 Jun 30, 2023 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2022 10-Q ↗	Q4 FY2021 Jun 30, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Sep 30, 2021 10-Q ↗	Q4 FY2020 Jun 30, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Sep 30, 2020 10-Q ↗	Q4 FY2019 Jun 30, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Dec 31, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Dec 31, 2018 10-Q ↗	Q1 FY2018 Sep 30, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-Q ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Dec 31, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-Q ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q1 FY2016 Sep 30, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-Q ↗	Q3 FY2015 Mar 31, 2015 10-Q ↗	Q2 FY2015 Dec 31, 2015 10-Q ↗	Q1 FY2015 Sep 30, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-Q ↗	Q3 FY2014 Mar 31, 2014 10-Q ↗	Q2 FY2014 Dec 31, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗
Return on Common Equity (%) (%)	—	—	—	-40.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-372%)	-32.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-317%)	-32.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-315%)	-39.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	-34.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-328%)	-67.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-551%)	-41.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-374%)	—	—	—	—	161.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+974%)	-139.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1033%)	—	—	-55.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-471%)	-29.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-295%)	—	75.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+403%)	-34.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-55.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-471%)	—	—	-9.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	—	—	—	-23.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-88.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-690%)	—	—	—	-33.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-322%)	—	—	—	-48.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-420%)	—	—	—	30.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+103%)	—	—	—	—	—	—	—	122.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+715%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q4 FY2028 Jun 30, 2019 10-K ↗	Q4 FY2027 Jun 30, 2018 10-K ↗	Q4 FY2026 Jun 30, 2017 10-K ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2013 10-Q ↗	Q4 FY2022 Jun 30, 2023 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2022 10-Q ↗	Q4 FY2021 Jun 30, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Sep 30, 2021 10-Q ↗	Q4 FY2020 Jun 30, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Sep 30, 2020 10-Q ↗	Q4 FY2019 Jun 30, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Dec 31, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Dec 31, 2018 10-Q ↗	Q1 FY2018 Sep 30, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-Q ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Dec 31, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-Q ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q1 FY2016 Sep 30, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-Q ↗	Q3 FY2015 Mar 31, 2015 10-Q ↗	Q2 FY2015 Dec 31, 2015 10-Q ↗	Q1 FY2015 Sep 30, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-Q ↗	Q3 FY2014 Mar 31, 2014 10-Q ↗	Q2 FY2014 Dec 31, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗
Debt to Equity (x)	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-68%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-3.72M	$-5.97M	$-6.56M	$2.60M	$-6.30M	$-3.62M	$-2.70M	$-8.51M	$-6.22M	$-12.66M	—	—	—	$-3.67M	—	$-1.53M	$-7.53M	$-1.53M	—	$-11.78M	—	$-11.78M	—	$-10.54M	—	$-10.54M	—	$-2.39M	—	$-2.39M	—	$-3.72M	$-2.15M	$-3.70M	$-3.88M	$-5.97M	—	$-11.02M	$-13.15M	$-6.59M	$-2.01M	$-3.42M	$-4.80M	$-6.16M	—	$-1.96M	—	$-1.75M	—	$-3.96M	—	$-4.76M	$-3.47M

📊 What does each share earn? 6 metrics

Metric	Q4 FY2028 Jun 30, 2019 10-K ↗	Q4 FY2027 Jun 30, 2018 10-K ↗	Q4 FY2026 Jun 30, 2017 10-K ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2013 10-Q ↗	Q4 FY2022 Jun 30, 2023 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2022 10-Q ↗	Q4 FY2021 Jun 30, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Sep 30, 2021 10-Q ↗	Q4 FY2020 Jun 30, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Sep 30, 2020 10-Q ↗	Q4 FY2019 Jun 30, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Dec 31, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Dec 31, 2018 10-Q ↗	Q1 FY2018 Sep 30, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-Q ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Dec 31, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-Q ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q1 FY2016 Sep 30, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-Q ↗	Q3 FY2015 Mar 31, 2015 10-Q ↗	Q2 FY2015 Dec 31, 2015 10-Q ↗	Q1 FY2015 Sep 30, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-Q ↗	Q3 FY2014 Mar 31, 2014 10-Q ↗	Q2 FY2014 Dec 31, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗
Revenue per Share (USD)	—	—	—	—	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	—	—	—	$-0.14	$-0.13	$-0.13	$-0.14	$-0.21	$-0.15	$0.16	$-0.54	$-0.43	$-0.40	$4.85	$-1.94	$-0.24	—	$13.12	$-5.45	$-2.10	$-0.00	$-24.33	$-0.00	$0.00	$-0.01	$-0.04	$0.00	$0.00	$-0.03	$-0.06	$0.01	$0.00	—	—	—	$0.02	$0.02	—	—	$0.03	—	—	—	—	$0.05	—	$0.01	$0.01	$0.03	—	$0.02	$0.01	—
Free Cash Flow per Share (USD)	—	—	—	$-0.14	$-0.07	—	$-0.22	—	$-0.11	—	$-0.27	$-0.42	$-0.31	—	$-4.12	$-0.49	—	—	$-6.99	—	$-0.00	—	$-0.00	—	$-0.00	—	$0.01	—	$-0.00	—	$-0.00	—	—	—	—	—	$-0.02	—	—	—	—	—	—	$-0.03	$-0.03	—	$-0.00	—	$-0.03	—	—	—	—
Book Value per Share (USD)	—	—	$1.34	$0.29	$0.36	$0.35	$0.33	$0.39	$0.23	$0.35	—	—	—	$-0.13	$-1.21	$0.17	$-0.01	—	$9.78	$7.18	—	—	$0.01	$0.00	—	—	$0.04	$0.00	—	—	$0.06	$0.00	$0.04	$0.98	$1.30	$1.19	—	$2.14	—	$1.34	$0.02	$0.05	$0.07	$0.09	—	—	—	$-0.00	—	$0.01	—	$0.00	$-0.02
Tangible Book Value per Share (USD)	—	—	$1.34	$0.12	$0.20	$0.17	$0.06	$0.12	$0.23	$0.35	—	—	—	$-0.13	$-1.21	$0.17	$-0.01	—	$9.78	$7.18	—	—	$0.01	$0.00	—	—	$0.04	$0.00	—	—	$0.06	$0.00	$0.04	$0.98	$1.30	$1.19	—	$2.14	—	$1.34	$0.02	$0.05	$0.07	$0.09	—	—	—	$-0.00	—	$0.01	—	$0.00	$-0.02
Basic Weighted Avg Shares (shares)	—	—	—	63.96M	60.01M	—	50.67M	44.56M	43.40M	—	12.18M	12.18M	12.17M	—	1.68M	4.34M	—	—	983,000	1.64M	3.66B	—	1.46B	2.43B	1.71B	—	570.85M	1.24B	855.30M	—	125.92M	570.39M	—	—	—	121.21M	114.85M	—	—	112.80M	—	—	—	57.12M	56.51M	—	194.88M	219.90M	53.10M	—	158.30M	188.99M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q4 FY2028 Jun 30, 2019 10-K ↗	Q4 FY2027 Jun 30, 2018 10-K ↗	Q4 FY2026 Jun 30, 2017 10-K ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2013 10-Q ↗	Q4 FY2022 Jun 30, 2023 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2022 10-Q ↗	Q4 FY2021 Jun 30, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Sep 30, 2021 10-Q ↗	Q4 FY2020 Jun 30, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Sep 30, 2020 10-Q ↗	Q4 FY2019 Jun 30, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Dec 31, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Dec 31, 2018 10-Q ↗	Q1 FY2018 Sep 30, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-Q ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Dec 31, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-Q ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q1 FY2016 Sep 30, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-Q ↗	Q3 FY2015 Mar 31, 2015 10-Q ↗	Q2 FY2015 Dec 31, 2015 10-Q ↗	Q1 FY2015 Sep 30, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-Q ↗	Q3 FY2014 Mar 31, 2014 10-Q ↗	Q2 FY2014 Dec 31, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗
Working Capital (USD)	$1.96M	$5.41M	$6.57M	$-7.60M	$915.38K	$-1.30M	$-5.33M	$-2.63M	$9.54M	$14.28M	—	—	—	$562.42K	—	$188.00K	—	$188.00K	—	$9.27M	—	$9.27M	—	$9.01M	—	$9.01M	—	$176.00K	—	$176.00K	—	—	$1.24M	$2.75M	$3.65M	$5.41M	—	$9.96M	$12.89M	$6.57M	$1.30M	$2.85M	$4.53M	$5.69M	—	$1.61M	—	$1.72M	—	—	—	—	—
LT Debt (USD)	—	$1.12K	$28.14K	$3.60M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$265.00	$76.00	$1.34K	—	—	$5.45K	$4.07K	—	$91.55K	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$1.97M	$5.44M	$6.58M	$18.50M	$23.19M	$20.93M	$16.78M	$19.45M	$9.86M	$14.59M	—	—	—	$-1.56M	$-2.03M	$731.00K	$-817.98K	$731.00K	$9.62M	$11.79M	—	$11.79M	$19.16M	$10.58M	—	$10.58M	$20.55M	$263.00K	—	$263.00K	$7.02M	$1.97M	$1.26M	$2.77M	$3.67M	$5.44M	—	$9.98M	$12.92M	$6.58M	$1.23M	$2.70M	$3.97M	$4.86M	—	$116.73K	—	$-821.49K	—	$2.09M	—	$880.48K	$-3.06M

📋 What is driving earnings? 4 metrics

Metric	Q4 FY2028 Jun 30, 2019 10-K ↗	Q4 FY2027 Jun 30, 2018 10-K ↗	Q4 FY2026 Jun 30, 2017 10-K ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2023 10-Q ↗	Q1 FY2023 Dec 31, 2013 10-Q ↗	Q4 FY2022 Jun 30, 2023 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2022 10-Q ↗	Q1 FY2022 Sep 30, 2022 10-Q ↗	Q4 FY2021 Jun 30, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2021 10-Q ↗	Q1 FY2021 Sep 30, 2021 10-Q ↗	Q4 FY2020 Jun 30, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2020 10-Q ↗	Q1 FY2020 Sep 30, 2020 10-Q ↗	Q4 FY2019 Jun 30, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Dec 31, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-Q ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Dec 31, 2018 10-Q ↗	Q1 FY2018 Sep 30, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-Q ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Dec 31, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-Q ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Dec 31, 2016 10-Q ↗	Q1 FY2016 Sep 30, 2016 10-Q ↗	Q4 FY2015 Dec 31, 2015 10-Q ↗	Q3 FY2015 Mar 31, 2015 10-Q ↗	Q2 FY2015 Dec 31, 2015 10-Q ↗	Q1 FY2015 Sep 30, 2015 10-Q ↗	Q4 FY2014 Dec 31, 2014 10-Q ↗	Q3 FY2014 Mar 31, 2014 10-Q ↗	Q2 FY2014 Dec 31, 2014 10-Q ↗	Q1 FY2014 Mar 31, 2014 10-Q ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	$28.10K	$23.47K	$22.54K	$21.29K	$14.00K	$14.06K	$17.64K	$29.14K	$35.63K	$34.31K	$132.00K	$15.00K	$15.00K	—	$15.00K	$15.00K	$15.00K	$15.00K	$45.00K	$-15.00K	—	$15.00K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	—	—	—	$-7.54M	$-7.54M	$-6.76M	$-6.66M	$-6.66M	$-6.66M	$-6.00M	$-4.84M	$-4.84M	$-4.84M	$-18.00M	$-3.26M	$-1.02M	$-7.41M	$2.57M	$-5.36M	$-3.45M	$-4.60M	$8.90M	$-6.63M	$-5.89M	$-5.97M	$-32.99M	$-1.96M	$-5.41M	$-19.52M	$-3.66M	$-1.66M	$-1.74M	—	—	—	$-1.81M	$-1.99M	—	—	$-3.16M	—	—	—	$1.48M	$-2.29M	—	$2.09M	—	$-1.62M	—	$4.87M	$1.08M	$-15.33M
Operating Cash Flow (USD)	—	—	—	$-8.63M	$-4.41M	$-5.56M	$-11.09M	—	$-4.74M	$-2.60M	$-3.23M	$-5.07M	$-3.83M	$-1.59M	$-6.92M	$-2.12M	—	$3.54M	$-6.87M	—	$-6.37M	$-6.22M	$-3.99M	—	$-5.07M	$-13.51M	$4.19M	—	$-4.11M	$-3.41M	$-537.67K	—	—	—	—	—	$-2.08M	—	—	—	—	—	—	$-1.45M	$-1.61M	—	$-409.18K	—	$-1.40M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 53 quarters

TuHURA Biosciences, Inc./NV

Analytical Summary

53-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare HURA with peers